HHS should act quickly to end travel restrictions for HIV-positive people, editorial says

NewsGuard 100/100 Score

HHS should take action "soon to end a de facto form of discrimination" by rewriting its rules prohibiting HIV-positive people from visiting the U.S., a Washington Post editorial says, adding that the continuation of the policy "puts the United States in the company of countries such as Libya, Saudi Arabia and Sudan."

According to the Post, Congress recently lifted a ban on allowing foreign visitors and immigrants living with HIV/AIDS into the country as part of the reauthorization of the President's Emergency Plan for AIDS Relief, but the ban will not be lifted "in practice" unless HHS rewrites its rules on the issue.

"President Bush's commitment to taking the fight against HIV/AIDS to Africa has earned the United States immeasurable goodwill abroad," the Post says, adding that PEPFAR is "one of the hallmark achievements" of the Bush administration. "But much of this goodwill is undone by the ban," the editorial says, concluding, "HHS officials have said that changing the rule is a 'time-consuming process' but that they're working to revise it before the next administration takes office. We hope this isn't just rhetoric and that HHS acts soon" (Washington Post, 9/26).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Watch: Many Americans are unaware of HIV prevention medication